Breast Tissue Markers Market Analysis | United States | 2016-2022 | MedCore

Breast Tissue Markers Market Analysis | United States | 2016-2022 | MedCore

0

The value of the U.S. breast tissue marker market is expected to increase modestly over the forecast period. Growth in the value of the market will be driven by increasing unit sales and limited by ASP erosion. The increasing incidence of breast cancer and utilization of breast tissue markers in percutaneous breast biopsies as well as axillary lymph node marking are expected to fuel unit sales growth over the next seven years. ASP erosion will be driven by commoditization of breast tissue markers with lower clinical value.

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Published Date: 11/1/2016
  • Pages: 32
  • Type: MedCore

Breast tissue markers are placed during roughly 80% of percutaneous breast biopsy procedures. Percutaneous breast biopsy procedures are typically performed using ultrasound guidance, stereotactic guidance or Magnetic Resonance Imaging (MRI) guidance. The volume of ultrasound guided percutaneous biopsy procedures performed annually in the U.S. is expected to increase over the forecast period, while the number of stereotactic-guided breast biopsy procedures is expected to decline. MRI-guided percutaneous breast biopsy procedure volume is expected to remain relatively stable through 2022. In the past, most breast tissue markers were designed for use with specific biopsy needles. In the future, an increasing number of breast tissue markers are expected to be designed for use with a wide range of biopsy needles.



The "US Market Report for Breast Tissue Markers and Breast Localization Wires 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Mammotome
Hologic
C.R. Bard
Somatex
Others Include: Argon Medical, Becton Dickinson, Mermaid Medical, Scion Medical Technologies, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link